SMAD5 is translocated into the nucleus and interacts with the BCAT1 promoter to stimulate BCAT1 expression in cancer-associated fibroblasts from pancreatic ductal adenocarcinoma (PDAC) tumors when the transforming growth factor is activated [108,111]. This evidence concerns the gene BCAT1 and pancreatic ductal adenocarcinoma.